Spineway SA (EPA:ALSPW)

Market Cap	3.17M +62.2%
Revenue (ttm)	12.43M -2.4%
Net Income	-2.24M
EPS	n/a
Shares Out	19.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,090
Average Volume	113,174
Open	0.1548
Previous Close	0.1546
Day's Range	0.1542 - 0.1618
52-Week Range	0.0960 - 0.2560
Beta	0.33
RSI	49.62
Earnings Date	Apr 29, 2026

About Spineway

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 43
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSPW

Financial Performance

In 2025, Spineway's revenue was 12.43 million, a decrease of -2.38% compared to the previous year's 12.73 million. Losses were -2.24 million, -42.10% less than in 2024.